Skip to main content
logo
IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
30.46
-1.63 (-5.08%)
Mar 27, 2026, 4:00 PM EDT - Market closed

IDEAYA Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,6753,0352,2232,314876911
Market Cap Growth
61.16%36.52%-3.93%164.27%-3.87%120.28%
Enterprise Value
1,6532,4231,5661,790512.45667.63
Last Close Price
30.4634.5725.7035.5818.1723.64
PE Ratio
--27.01-7.65-18.15-12.80-16.77
PS Ratio
12.236.94158.8049.488.6016.30
PB Ratio
2.612.972.103.732.513.02
P/TBV Ratio
2.642.991.983.302.152.76
P/FCF Ratio
--41.31-8.84-19.68-9.66-15.59
P/OCF Ratio
--42.69-8.98-20.08-10.04-16.33
EV/Sales Ratio
7.565.54111.8438.275.0311.95
EV/EBITDA Ratio
--15.66-4.85-13.73-8.69-14.13
EV/EBIT Ratio
--15.21-4.79-13.32-8.20-13.28
EV/FCF Ratio
--32.99-6.23-15.22-5.66-11.43
Debt / Equity Ratio
0.030.030.020.000.000.01
Debt / EBITDA Ratio
-0.18-0.18-0.06-0.02-0.06-0.11
Debt / FCF Ratio
-0.38-0.38-0.08-0.02-0.04-0.09
Net Debt / Equity Ratio
-0.60-0.60-0.62-0.84-1.03-0.80
Net Debt / EBITDA Ratio
3.953.952.034.006.135.12
Net Debt / FCF Ratio
8.328.322.614.443.994.14
Asset Turnover
0.390.390.020.090.260.16
Quick Ratio
10.8710.8714.6819.3811.515.49
Current Ratio
11.3411.3414.9719.6511.685.56
Return on Equity (ROE)
-10.92%-10.92%-32.67%-23.28%-18.02%-19.91%
Return on Assets (ROA)
-14.27%-14.27%-36.88%-25.92%-16.25%-14.79%
Return on Invested Capital (ROIC)
-39.17%-39.17%-130.57%-266.97%-102.45%-80.19%
Return on Capital Employed (ROCE)
-14.97%-14.97%-38.46%-27.48%-18.05%-16.87%
Earnings Yield
-4.25%-3.70%-13.07%-5.51%-7.82%-5.96%
FCF Yield
-2.75%-2.42%-11.31%-5.08%-10.35%-6.41%
Buyback Yield / Dilution
-8.33%-8.33%-42.00%-38.79%-17.57%-42.60%
Total Shareholder Return
-8.33%-8.33%-42.00%-38.79%-17.57%-42.60%
Updated Feb 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q